Erratum: Mathur A, Moses W, Rahbari R, Khanafshar E, Duh QY, Clark O and Kebebew E. Higher rate of BRAF mutation in papillary thyroid cancer over time. Cancer. 2011;117:4390-5

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|2|324-324

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.2, 2015-01, pp. : 324-324

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Potential of Liquid Biopsy in Papillary Thyroid Carcinoma in Context of miRNA, BRAF and p53 Mutation

By  

Current Drug Targets, Vol. 19, Iss. 14, 2018-10 ,pp. : 1721-1729

Bentham Science Publishers

Access to resources Recommend Favorite

R-Flurbiprofen (E-7869), a chemopreventive and treatment of cancer

By Wechter W. J.   Leipold D. D.   Quiggle D. D.   McCracken J. D.   Murray Jr.- E. D.   Loughman B. E.  

Inflammopharmacology, Vol. 8, Iss. 2, 2000-06 ,pp. : 189-206

VSP

Access to resources Recommend Favorite

Cost-effectiveness analysis of papillary thyroid cancer surveillance

By  

Cancer, Vol. 121, Iss. 23, 2015-12 ,pp. : 4132-4140

Blackwell Publishing

Access to resources Recommend Favorite

Minocycline: Black thyroid and papillary thyroid cancer: case report

By  

Reactions Weekly, Vol. 1, Iss. 1164, 2007-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Preoperative BRAF(V600E) mutation screening is unlikely to alter initial surgical treatment of patients with indeterminate thyroid nodules: A prospective case series of 960 patients

By Lodewijk Lutske   Kist Jakob W.   Valk Gerlof D.   Vriens Menno R.   Borel Rinkes Inne H.M.  

Cancer, Vol. 120, Iss. 7, 2014-04 ,pp. : 1083-1084

Blackwell Publishing

Access to resources Recommend Favorite